The therapeutic potential of hydrogen sulfide: Separating hype from hope

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 301, Issue 2, 2011, Pages

  Olson, Kenneth R ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Gasotransmitter; Hydrogen sulfide donating drugs; Ischemia reperfusion injury; Sulfur cycle; Vasoactivity

Indexed keywords

GYY 4137; HYDROGEN SULFIDE; MORPHOLIN 4 IUM 4 METHOXYPHENYL(MORPHOLINO)PHOSPHINODITHIOATE; TOXIC GAS; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; BIOSYNTHESIS; CARDIOVASCULAR SYSTEM; CONCENTRATION (PARAMETERS); DRUG STRUCTURE; GASTROINTESTINAL TRACT; HUMAN; INFLAMMATION; METABOLISM; NERVOUS SYSTEM; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; RESPIRATORY SYSTEM; SIGNAL TRANSDUCTION; SULFUR CYCLE;

ANIMALS; HYDROGEN SULFIDE; SIGNAL TRANSDUCTION; VERTEBRATES;

EID: 79961076132     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00045.2011     Document Type: Article

References (208)

1. Abe K, Kimura H. The possible role of hydrogen sulfide as an endogenous neuromodulator. J Neurosci 16: 1066-1071, 1996.
2. Ali MY, Ping CY, Mok YY, Ling L, Whiteman M, Bhatia M, Moore PK. Regulation of vascular nitric oxide in vitro and in vivo; a new role for endogenous hydrogen sulphide? Br J Pharmacol 149: 625-634, 2006.
3. Aslami H, Heinen A, Roelofs JJ, Zuurbier CJ, Schultz MJ, Juffermans NP. Suspended animation inducer hydrogen sulfide is protective in an in vivo model of ventilator-induced lung injury. Intensive Care Med 36: 1946-1952, 2010.
4. Aslami H, Schultz MJ, Juffermans NP. Potential applications of hydrogen sulfide-induced suspended animation. Curr Med Chem 16: 1295-1303, 2009.
5. Attene-Ramos MS, Nava GM, Muellner MG, Wagner ED, Plewa MJ, Gaskins HR. DNA damage and toxicogenomic analyses of hydrogen sulfide in human intestinal epithelial FHs 74 Int cells. Environ Mol Mutagen 51: 304-314, 2010.
6. Bagarinao T. Sulfide as an environmental factor and toxicant: tolerance and adaptations in aquatic organisms. Aquat Toxicol (Amst) 24: 21-62, 1992.
7. Balazy M, bu-Yousef IA, Harpp DN, Park J. Identification of carbonyl sulfide and sulfur dioxide in porcine coronary artery by gas chromatography/mass spectrometry, possible relevance to EDHF. Biochem Biophys Res Commun 311: 728-734, 2003.
8. Banerjee R, Zou CG. Redox regulation and reaction mechanism of human cystathionine-beta-synthase: a PLP-dependent hemesensor protein. Arch Biochem Biophys 433: 144-156, 2005.
9. Bannenberg GL, Vieira HL. Therapeutic applications of the gaseous mediators carbon monoxide and hydrogen sulfide. Expert Opin Ther Pat 19: 663-682, 2009.
10. Baskar R, Sparatore A, Del SP, Moore PK. Effect of S-diclofenac, a novel hydrogen sulfide releasing derivative inhibit rat vascular smooth muscle cell proliferation. Eur J Pharmacol 594: 1-8, 2008.
11. Baumgart K, Radermacher P, Wagner F. Applying gases for microcirculatory and cellular oxygenation in sepsis: effects of nitric oxide, carbon monoxide, and hydrogen sulfide. Curr Opin Anaesthesiol 22: 168-176, 2009.
12. Baumgart K, Wagner F, Groger M, Weber S, Barth E, Vogt JA, Wachter U, Huber-Lang M, Knoferl MW, Albuszies G, Georgieff M, Asfar P, Szabo C, Calzia E, Radermacher P, Simkova V. Cardiac and metabolic effects of hypothermia and inhaled hydrogen sulfide in anesthetized and ventilated mice. Crit Care Med 38: 588-595, 2010.
13. Bearden SE, Beard RS Jr, Pfau JC. Extracellular transsulfuration generates hydrogen sulfide from homocysteine and protects endothelium from redox stress. Am J Physiol Heart Circ Physiol 299: H1568-H1576, 2010.
14. Beltowski J. Hypoxia in the renal medulla: Implications for hydrogen sulfide signaling. J Pharmacol Exp Ther 334: 358-363, 2010.
15. Beltowski J, Jamroz-Wisniewska A, Tokarzewska D. Hydrogen sulfide and its modulation in arterial hypertension and atherosclerosis. Cardiovasc Hematol Agents Med Chem 8: 173-186, 2010.
16. Benavides GA, Squadrito GL, Mills RW, Patel HD, Isbell TS, Patel RP, Darley-Usmar VM, Doeller JE, Kraus DW. Hydrogen sulfide mediates the vasoactivity of garlic. Proc Natl Acad Sci USA 104: 17977-17982, 2007.
17. Bhatia M, Wong FL, Fu D, Lau HY, Moochhala SM, Moore PK. Role of hydrogen sulfide in acute pancreatitis and associated lung injury. FASEB J 19: 623-625, 2005.
18. Brittain T, Yosaatmadja Y, Henty K. The interaction of human neuroglobin with hydrogen sulphide. IUBMB Life 60: 135-138, 2008.
19. Calabrese V, Cornelius C, nkova-Kostova AT, Calabrese EJ, Mattson MP. Cellular stress responses, the hormesis paradigm, and vitagenes: novel targets for therapeutic intervention in neurodegenerative disorders. Antioxid Redox Signal 13: 1763-1811 2010.
20. Caliendo G, Cirino G, Santagada V, Wallace JL. Synthesis and biological effects of hydrogen sulfide (H2S): development of H2Sreleasing drugs as pharmaceuticals. J Med Chem 53: 6275-6286, 2010.
21. Carballal S, Trujillo M, Cuevasanta E, Bartesaghi S, Moller MN, Folkes LK, Garcia-Bereguiain MA, Gutierrez-Merino C, Wardman P, Denicola A, Radi R, Alvarez B. Reactivity of hydrogen sulfide with peroxynitrite and other oxidants of biological interest. Free Radic Biol Med 50: 196-205, 2010.
22. Chen YH, Wu R, Geng B, Qi YF, Wang PP, Yao WZ, Tang CS. Endogenous hydrogen sulfide reduces airway inflammation and remodeling in a rat model of asthma. Cytokine 45: 117-123, 2009.
23. 2S biogenesis by human cystathionine gamma-lyase leads to the novel sulfur metabolites lanthionine and homolanthionine and is responsive to the grade of hyperhomocysteinemia. J Biol Chem 284: 11601-11612, 2009.
24. Collman JP, Ghosh S, Dey A, Decreau RA. Using a functional enzyme model to understand the chemistry behind hydrogen sulfide-induced hibernation. Proc Natl Acad Sci USA 106: 22090-22095, 2009.
25. Curtis CG, Bartholomew TC, Rose FA, Dodgson KS. Detoxication of sodium 35 S-sulphide in the rat. Biochem Pharmacol 21: 2313-2321, 1972.
26. Demmanuele di Villa Bianca R, Sorrentino R, Maffia P, Mirone V, Imbimbo C, Fusco F, De Palma R, Ignarro LJ, Cirino G. Hydrogen sulfide as a mediator of human corpus cavernosum smooth-muscle relaxation. Proc Natl Acad Sci USA 106: 4513-4518, 2009.
27. DeBruyn WJ, Swartz E, Hu JH, Shorter JA, Davidovits P, Worsnop DR, Zahniser MS, Kolb CE. Henry's law solubilities and Setchenow coefficients for biogenic reduced sulfur species obtained from gas-liquid uptake measurements. J Geophys Res 100: 7245-7251, 1995.
28. Dhaese I, Lefebvre RA. Myosin light chain phosphatase activation is involved in the hydrogen sulfide-induced relaxation in mouse gastric fundus. Eur J Pharmacol 606: 180-186, 2009.
29. Dhaese I, van Colen, I, Lefebvre RA. Mechanisms of action of hydrogen sulfide in relaxation of mouse distal colonic smooth muscle. Eur J Pharmacol 628: 179-186, 2010.
30. Distrutti E, Cipriani S, Renga B, Mencarelli A, Migliorati M, Cianetti S, Fiorucci S. Hydrogen sulphide induces micro opioid receptor- dependent analgesia in a rodent model of visceral pain [Online]. Mol Pain 6: 36, 2010.
31. Dombkowski RA, Doellman MM, Head SK, Olson KR. Hydrogen sulfide mediates hypoxia-induced relaxation of trout urinary bladder smooth muscle. J Exp Biol 209: 3234-3240, 2006.
32. Dombkowski RA, Russell MJ, Schulman AA, Doellman MM, Olson KR. Vertebrate phylogeny of hydrogen sulfide vasoactivity. Am J Physiol Regul Integr Comp Physiol 288: R243-R252, 2005.
33. Dominy JE, Stipanuk MH. New roles for cysteine and transsulfuration enzymes: production of H2S, a neuromodulator and smooth muscle relaxant. Nutr Rev 62: 348-353, 2004.
34. Dorman DC, Moulin FJ, McManus BE, Mahle KC, James RA, Struve MF. Cytochrome oxidase inhibition induced by acute hydrogen sulfide inhalation: correlation with tissue sulfide concentrations in the rat brain, liver, lung, and nasal epithelium. Toxicol Sci 65: 18-25, 2002.
35. Elsey DJ, Fowkes RC, Baxter GF. L-cysteine stimulates hydrogen sulfide synthesis in myocardium associated with attenuation of ischemiareperfusion injury. J Cardiovasc Pharmacol Ther 15: 53-59, 2010.
36. 2S). Cell Biochem Funct 28: 95-106, 2010.
37. Eto K, Asada T, Arima K, Makifuchi T, Kimura H. Brain hydrogen sulfide is severely decreased in Alzheimer's disease. Biochem Biophys Res Commun 293: 1485-1488, 2002.
38. Evans CL. The toxicity of hydrogen sulphide and other sulphides. Q J Exp Physiol 52: 231-248, 1967.
39. Fujii K, Sakuragawa T, Kashiba M, Sugiura Y, Kondo M, Maruyama K, Goda N, Nimura Y, Suematsu M. Hydrogen sulfide as an endogenous modulator of biliary bicarbonate excretion in the rat liver. Antioxid Redox Signal 7: 788-794, 2005.
40. Fukushima O, Nishimura S, Matsunami M, Aoki Y, Nishikawa H, Ishikura H, Kawabata A. Phosphorylation of ERK in the spinal dorsal horn following pancreatic pronociceptive stimuli with proteinase-activated receptor-2 agonists and hydrogen sulfide in rats: Evidence for involvement of distinct mechanisms. J Neurosci Res 88: 3198-3205, 2010.
41. Furne J, Saeed A, Levitt MD. Whole tissue hydrogen sulfide concentrations are orders of magnitude lower than presently accepted values. Am J Physiol Regul Integr Comp Physiol 295: R1479-R1485, 2008.
42. Gadalla MM, Snyder SH. Hydrogen sulfide as a gasotransmitter. J Neurochem 113: 14-26, 2010.
43. Giustarini D, Del SP, Sparatore A, Rossi R. Modulation of thiol homeostasis induced by H2S-releasing aspirin. Free Radic Biol Med 48: 1263-1272, 2010.
44. Gong QH, Pan LL, Liu XH, Wang Q, Huang H, Zhu YZ. Spropargyl- cysteine (ZYZ-802), a sulphur-containing amino acid, attenuates β-amyloid-induced cognitive deficits and pro-inflammatory response: involvement of ERK1/2 and NF-B pathway in rats. Amino Acids 40: 601-610, 2011.
45. Goubern M, Andriamihaja M, Nubel T, Blachier F, Bouillaud F. Sulfide, the first inorganic infstrate for human cells. FASEB J 21: 1699-1706, 2007.
46. Guidotti TL. Hydrogen sulfide: advances in understanding human toxicity. Int J Toxicol 29: 569-581, 2010.
47. Haggard HW. The fate of sulfites in the blood. J Biol Chem 49:519-529, 1921.
48. Hart JL. Role of sulfur-containing gaseous infstances in the cardiovascular system. Front Biosci 3: 736-749, 2011.
49. Henderson PW, Jimenez N, Ruffino J, Sohn AM, Weinstein AL, Krijgh DD, Reiffel AJ, Spector JA. Therapeutic delivery of hydrogen sulfide for salvage of ischemic skeletal muscle after the onset of critical ischemia. J Vasc Surg 53: 785-791, 2011.
50. Henderson PW, Singh SP, Belkin D, Nagineni V, Weinstein AL, Weissich J, Spector JA. Hydrogen sulfide protects against ischemiareperfusion injury in an in vitro model of cutaneous tissue transplantation. J Surg Res 159: 451-455, 2010.
51. Henderson PW, Singh SP, Weinstein AL, Nagineni V, Rafii DC, Kadouch D, Krijgh DD, Spector JA. Therapeutic metabolic inhibition: hydrogen sulfide significantly mitigates skeletal muscle ischemia reperfusion injury in vitro and in vivo. Plast Reconstr Surg 126: 1890-1898, 2010.
52. Henderson PW, Weinstein AL, Sohn AM, Jimenez N, Krijgh DD, Spector JA. Hydrogen sulfide attenuates intestinal ischemia-reperfusion injury when delivered in the post-ischemic period. J Gastroenterol Hepatol 25: 1642-1647, 2010.
53. Hildebrandt TM, Grieshaber MK. Three enzymatic activities catalyze the oxidation of sulfide to thiosulfate in mammalian and invertebrate mitochondria. FEBS J 275: 3352-3361, 2008.
54. Hosoki R, Matsuki N, Kimura H. The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide. Biochem Biophys Res Commun 237: 527-531, 1997.
55. Hu LF, Lu M, Tiong CX, Dawe GS, Hu G, Bian JS. Neuroprotective effects of hydrogen sulfide on Parkinson's disease rat models. Aging Cell 9: 135-146, 2010.
56. Hu LF, Lu M, Wong PT, Bian JS. Hydrogen sulfide: neurophysiology and neuropathology. Antioxid Redox Signal. In press.
57. Huang Y, Li F, Tong W, Zhang A, He Y, Fu T, Liu B. Hydrogen sulfide, a gaseous transmitter, stimulates proliferation of interstitial cells of Cajal via phosphorylation of AKT protein kinase. Tohoku J Exp Med 221: 125-132, 2010.
58. Hughes MN, Centelles MN, Moore KP. Making and working with hydrogen sulfide: The chemistry and generation of hydrogen sulfide in vitro and its measurement in vivo: a review. Free Radic Biol Med 47:1346-1353, 2009.
59. Insko MA, Deckwerth TL, Hill P, Toombs CF, Szabó C. Detection of exhaled hydrogen sulphide gas in rats exposed to intravenous sodium sulphide. Br J Pharmacol 157: 944-951, 2009.
60. Ishigami M, Hiraki K, Umemura K, Ogasawara Y, Ishii K, Kimura H. A source of hydrogen sulfide and a mechanism of its release in the brain. Antioxid Redox Signal 11: 205-214, 2009.
61. Jackson SJ, Singletary KW, Venema RC. Sulforaphane suppresses angiogenesis and disrupts endothelial mitotic progression and microtubule polymerization. Vascul Pharmacol 46: 77-84, 2007.
62. Jeong SO, Pae HO, Oh GS, Jeong GS, Lee BS, Lee S, Kim DY, Rhew HY, Lee KM, Chung HT. Hydrogen sulfide potentiates interleukin-1β-induced nitric oxide production via enhancement of extracellular signalregulated kinase activation in rat vascular smooth muscle cells. Biochem Biophys Res Commun 345: 938-944, 2006.
63. Jiang B, Tang G, Cao K, Wu L, Wang R. Molecular mechanism for H2S-induced activation of K(ATP) channels. Antioxid Redox Signal 12: 1167-1178, 2010.
64. Jimenez M. Hydrogen sulfide as a signaling molecule in the enteric nervous system. Neurogastroenterol Motil 22: 1149-1153, 2010.
65. Julian D, Statile JL, Wohlgemuth SE, Arp AJ. Enzymatic hydrogen sulfide production in marine invertebrate tissues. Comp Biochem Physiol [A] Mol Integr Physiol 133: 105-115, 2002.
66. Kabil O, Banerjee R. Redox biochemistry of hydrogen sulfide. J Biol Chem 285: 21903-21907, 2010.
67. Kajimura M, Fukuda R, Bateman RM, Yamamoto T, Suematsu M. Interactions of multiple gas-transducing systems: hallmarks and uncertainties of CO, NO, and H2S gas biology. Antioxid Redox Signal 13: 157-192, 2010.
68. Kalir A, Kalir HK. Biological activity of sulfinic acid derivatives. In: The Chemistry of Sulfinic acids, Esters and Their Derivatives, edited by Patai S. New York, NY: John Wiley and Sons, 1990, p. 665-676.
69. Kamboures MA, Blake DR, Cooper DM, Newcomb RL, Barker M, Larson JK, Meinardi S, Nussbaum E, Rowland FS. Breath sulfides and pulmonary function in cystic fibrosis. Proc Natl Acad Sci USA 102: 15762-15767, 2005.
70. Kamoun P, Belardinelli MC, Chabli A, Lallouchi K, Chadefaux- Vekemans B. Endogenous hydrogen sulfide overproduction in Down syndrome. Am J Med Genet A 116A: 310-311, 2003.
71. Kasparek MS, Linden DR, Kreis ME, Sarr MG. Gasotransmitters in the gastrointestinal tract. Surgery 143: 455-459, 2008.
72. Kida K, Yamada M, Tokuda K, Marutani E, Kakinohana M, Kaneki M, Ichinose F. Inhaled hydrogen sulfide prevents neurodegeneration and movement disorder in a mouse model of Parkinson's disease. Antioxid Redox Signal. In press.
73. Kilburn KH, Thrasher JD, Gray MR. Low-level hydrogen sulfide and central nervous system dysfunction. Toxicol Ind Health 26: 387-405, 2010.
74. Kimura H. Hydrogen sulfide: from brain to gut. Antioxid Redox Signal 12: 1111-1123, 2010.
75. Kimura H. Hydrogen sulfide: its production, release and functions. Amino Acids. In press.
76. Kimura Y, Goto Y, Kimura H. Hydrogen sulfide increases glutathione production and suppresses oxidative stress in mitochondria. Antioxid Redox Signal 12: 1-13, 2010.
77. Kiss L, Deitch EA, Szabó C. Hydrogen sulfide decreases adenosine triphosphate levels in aortic rings and leads to vasorelaxation via metabolic inhibition. Life Sci 83: 589-594, 2008.
78. Koenitzer JR, Isbell TS, Patel HD, Benavides GA, Dickinson DA, Patel RP, Darley-Usmar VM, Lancaster JR Jr, Doeller JE, Kraus DW. Hydrogen sulfide mediates vasoactivity in an O2-dependent manner. Am J Physiol Heart Circ Physiol 292: H1953-H1960, 2007.
79. Krueger D, Foerster M, Mueller K, Zeller F, Slotta-Huspenina J, Donovan J, Grundy D, Schemann M. Signaling mechanisms involved in the intestinal pro-secretory actions of hydrogen sulfide. Neurogastroenterol Motil 22: 224-1231, 2010.
80. Kubo S, Doe I, Kurokawa Y, Kawabata A. Hydrogen sulfide causes relaxation in mouse bronchial smooth muscle. J Pharm Sci 104: 392-396, 2007.
81. Kubo S, Doe I, Kurokawa Y, Nishikawa H, Kawabata A. Direct inhibition of endothelial nitric oxide synthase by hydrogen sulfide: contribution to dual modulation of vascular tension. Toxicology 232: 138-146, 2007.
82. Lagoutte E, Mimoun S, Andriamihaja M, Chaumontet C, Blachier F, Bouillaud F. Oxidation of hydrogen sulfide remains a priority in mammalian cells and causes reverse electron transfer in colonocytes. Biochim Biophys Acta 1797: 1500-1511, 2010.
83. Lavu M, Bhushan S, Lefer DJ. Hydrogen sulfide-mediated cardioprotection:mechanisms and therapeutic potential. Clin Sci 120: 219-229, 2010.
84. Lee M, Tazzari V, Giustarini D, Rossi R, Sparatore A, Del SP, McGeer E, McGeer PL. Effects of hydrogen sulfide-releasing L-DOPA derivatives on glial activation: potential for treating Parkinson disease. J Biol Chem 285: 17318-17328, 2010.
85. Lefer DJ. Potential importance of alterations in hydrogen sulphide (H2S) bioavailability in diabetes. Br J Pharmacol 155: 617-619, 2008.
86. Leffler CW, Parfenova H, Basuroy S, Jaggar JH, Umstot ES, Fedinec AL. Hydrogen sulfide and cerebral microvascular tone in newborn pigs. Am J Physiol Heart Circ Physiol 300: H440-H447, 2011.
87. Leffler CW, Parfenova H, Jaggar JH, Wang R. Carbon monoxide and hydrogen sulfide: gaseous messengers in cerebrovascular circulation. J Appl Physiol 100: 1065-1076, 2006.
88. Li J, Li Y, Du Y, Mou K, Sun H, Zang Y, Liu C. Endogenous hydrogen sulfide as a mediator of vas deferens smooth muscle relaxation. Fertil Steril 95: 1833-1835, 2010.
89. Li L, Hsu A, Moore PK. Actions and interactions of nitric oxide, carbon monoxide and hydrogen sulphide in the cardiovascular system and in inflammation-a tale of three gases! Pharmacol Ther 123: 386-400, 2009.
90. Li L, Rose P, Moore PK. Hydrogen sulfide and cell signaling. Annu Rev Pharmacol Toxicol 51: 169-187, 2011.
91. Li L, Rossoni G, Sparatore A, Lee LC, Del SP, Moore PK. Antiinflammatory and gastrointestinal effects of a novel diclofenac derivative. Free Radic Biol Med 42: 706-719, 2007.
92. Li L, Whiteman M, Guan YY, Neo KL, Chengy Lee SW, Zhao Y, Baskar R, Tan CH, Moore PK. Characterization of a novel, watersoluble hydrogen sulfide-releasing molecule (GYY4137): new insights into the biology of hydrogen sulfide. Circulation 117: 2351-2360, 2008.
93. Li T, Zhao B, Wang C, Wang H, Liu Z, Li W, Jin H, Tang C, Du J. Regulatory effects of hydrogen sulfide on IL-6, IL-8 and IL-10 levels in the plasma and pulmonary tissue of rats with acute lung injury. Exp Biol Med (Maywood) 233: 1081-1087, 2008.
94. Li YF, Xiao CS, Hui RT. Calcium sulfide (CaS), a donor of hydrogen sulfide (H2S): a new antihypertensive drug? Med Hypotheses 73: 445-447, 2009.
95. Lim JJ, Liu YH, Khin ES, Bian JS. Vasoconstrictive effect of hydrogen sulfide involves downregulation of cAMP in vascular smooth muscle cells. Am J Physiol Cell Physiol 295: C1261-C1270, 2008.
96. Linden DR, Levitt MD, Farrugia G, Szurszewski JH. Endogenous production of H2S in the gastrointestinal tract: still in search of a physiologic function. Antioxid Redox Signal 12: 1135-1146, 2010.
97. Liu YH, Bian JS. Bicarbonate-dependent effect of hydrogen sulfide on vascular contractility in rat aortic rings. Am J Physiol Cell Physiol 299: C866-C872, 2010.
98. Lu M, Choo CH, Hu LF, Tan BH, Hu G, Bian JS. Hydrogen sulfide regulates intracellular pH in rat primary cultured glia cells. Neurosci Res 66: 92-98, 2010.
99. Lu M, Liu YH, Goh HS, Wang JJ, Yong QC, Wang R, Bian JS. Hydrogen sulfide inhibits plasma renin activity. J Am Soc Nephrol 21: 993-1002, 2010.
100. Maione S, Leyva J, Palazzo E, Stella L, Rossi F. L-Cysteinesulfinic acid modulates cardiovascular function in the periaqueductal gray area of rat. J Cardiovasc Pharmacol 32: 650-653, 1998.
101. Mancardi D, Penna C, Merlino A, Del SP, Wink DA, Pagliaro P. Physiological and pharmacological features of the novel gasotransmitter: Hydrogen sulfide. Biochim Biophys Acta 1787: 864-872, 2009.
102. Mancuso C, Navarra P, Preziosi P. Roles of nitric oxide, carbon monoxide, and hydrogen sulfide in the regulation of the hypothalamicpituitary-adrenal axis. J Neurochem 113: 563-575, 2010.
103. Maron BA, Loscalzo J. The treatment of hyperhomocysteinemia. Annu Rev Med 60: 39-54, 2009.
104. Martelli A, Testai L, Breschi MC, Blandizzi C, Virdis A, Taddei S, Calderone V. Hydrogen sulphide: novel opportunity for drug discovery. Med Res Rev In press.
105. Martin GR, McKnight GW, Dicay MS, Coffin CS, Ferraz JG, Wallace JL. Hydrogen sulphide synthesis in the rat and mouse gastrointestinal tract. Dig Liver Dis 42: 103-109, 2010.
106. Medani M, Collins D, Docherty NG, Baird AW, O'Connell PR, Winter DC. Emerging role of hydrogen sulfide in colonic physiology and pathophysiology. Inflamm Bowel Dis. In press.
107. Morii D, Miyagatani Y, Nakamae N, Murao M, Taniyama K. Japanese experience of hydrogen sulfide: the suicide craze in 2008. J Occup Med Toxicol 5: 28, 2010.
108. Mukherjee S, Lekli I, Ray D, Gangopadhyay H, Raychaudhuri U, Das DK. Comparison of the protective effects of steamed and cooked broccolis on ischaemia-reperfusion-induced cardiac injury. Br J Nutr 103: 815-823, 2010.
109. 2S signals through protein S-sulfhydration. Sci Signal 2: ra72, 2009.
110. Mustafa AK, Gadalla MM, Snyder SH. Signaling by gasotransmitters. Sci Signal 2: re2, 2009.
111. 2S-donating sildenafil (ACS6) inhibits superoxide formation and gp91phox expression in arterial endothelial cells: role of protein kinases A and G. Br J Pharmacol 155: 984-994, 2008.
112. Muzaffar S, Shukla N, Bond M, Newby AC, Angelini GD, Sparatore A, Del SP, Jeremy JY. Exogenous hydrogen sulfide inhibits superoxide formation, NOX-1 expression and Rac1 activity in human vascular smooth muscle cells. J Vasc Res 45: 521-528, 2008.
113. Nagao M, Linden DR, Duenes JA, Sarr MG. Mechanisms of action of the gasotransmitter hydrogen sulfide in modulating contractile activity of longitudinal muscle of rat ileum. J Gastrointest Surg 15: 12-22, 2011.
114. Nicholson CK, Calvert JW. Hydrogen sulfide and ischemia-reperfusion injury. Pharmacol Res 62: 289-297, 2010.
115. Olson KR. Vascular actions of hydrogen sulfide in non-mammalian vertebrates. Antioxid Redox Signal 7: 804-812, 2005.
116. Olson KR. Is hydrogen sulfide a circulating "gasotransmitter" in vertebrate blood? Biochim Biophys Acta 1787: 856-863, 2009.
117. Olson KR, Dombkowski RA, Russell MJ, Doellman MM, Head SK, Whitfield NL, Madden JA. Hydrogen sulfide as an oxygen sensor/transducer in vertebrate hypoxic vasoconstriction and hypoxic vasodilation. J Exp Biol 209: 4011-4023, 2006.
118. Olson KR, Whitfield NL. Hydrogen sulfide and oxygen sensing in the cardiovascular system. Antioxid Redox Signal 12: 1219-1234, 2010.
119. Olson KR, Whitfield NL, Bearden SE, St LJ, Nilson E, Gao Y, Madden JA. Hypoxic pulmonary vasodilation: A paradigm shift with a hydrogen sulfide mechanism. Am J Physiol Regul Integr Comp Physiol 298: R51-R60, 2010.
120. Otulakowski G, Kavanagh BP. Hydrogen sulfide in lung injury: therapeutic hope from a toxic gas? Anesthesiology 113: 4-6, 2010.
121. Pae HO, Lee YC, Jo EK, Chung HT. Subtle interplay of endogenous bioactive gases (NO, CO, and H2S) in inflammation. Arch Pharm Res 32: 1155-1162, 2009.
122. Parajuli SP, Choi S, Lee J, Kim YD, Park CG, Kim MY, Kim HI, Yeum CH, Jun JY. The inhibitory effects of hydrogen sulfide on pacemaker activity of interstitial cells of Cajal from mouse small intestine. Korean J Physiol Pharmacol 14: 83-89, 2010.
123. Patel P, Vatish M, Heptinstall J, Wang R, Carson RJ. The endogenous production of hydrogen sulphide in intrauterine tissues [Online]. Reprod Biol Endocrinol 7: 10, 2009.
124. Peng YJ, Nanduri J, Raghuraman G, Souvannakitti D, Gadalla MM, Kumar GK, Snyder SH, Prabhakar NR. H2S mediates O2 sensing in the carotid body. Proc Natl Acad Sci USA 107: 10719-10724, 2010.
125. Perna AF, Luciano MG, Ingrosso D, Pulzella P, Sepe I, Lanza D, Violetti E, Capasso R, Lombardi C, De Santo NG. Hydrogen sulphidegenerating pathways in haemodialysis patients: a study on relevant metabolites and transcriptional regulation of genes encoding for key enzymes. Nephrol Dial Transplant 24: 3756-3763, 2009.
126. Perrino E, Cappelletti G, Tazzari V, Giavini E, Del SP, Sparatore A. New sulfurated derivatives of valproic acid with enhanced histone deacetylase inhibitory activity. Bioorg Med Chem Lett 18: 1893-1897, 2008.
127. Pietri R, Roman-Morales E, Lopez-Garriga J. Hydrogen sulfide and hemeproteins: knowledge and mysteries. Antioxid Redox Signal. In press.
128. Predmore BL, Lefer DJ. Development of hydrogen sulfide-based therapeutics for cardiovascular disease. J Cardiovasc Transl Res 3: 487-498, 2010.
129. Qu K, Chen CP, Halliwell B, Moore PK, Wong PT. Hydrogen sulfide is a mediator of cerebral ischemic damage. Stroke 37: 889-893, 2006.
130. Qu K, Lee SW, Bian JS, Low CM, Wong PT. Hydrogen sulfide: Neurochemistry and neurobiology. Neurochem Int 52: 155-165, 2007.
131. Renga B, Mencarelli A, Migliorati M, Distrutti E, Fiorucci S. Bileacid-activated farnesoid X receptor regulates hydrogen sulfide production and hepatic microcirculation. World J Gastroenterol 15: 2097-2108, 2009.
132. Rossoni G, Sparatore A, Tazzari V, Manfredi B, Del SP, Berti F. The hydrogen sulphide-releasing derivative of diclofenac protects against ischaemia-reperfusion injury in the isolated rabbit heart. Br J Pharmacol 153: 100-109, 2008.
133. Rowan FE, Docherty NG, Coffey JC, O'Connell PR. Sulphate-reducing bacteria and hydrogen sulphide in the aetiology of ulcerative colitis. Br J Surg 96: 151-158, 2009.
134. Schenk S, Kesselmeier J, Anders E. How does the exchange of one oxygen atom with sulfur affect the catalytic cycle of carbonic anhydrase? Chemistry 10: 3091-3105, 2004.
135. Sehnert SS, Jiang L, Burdick JF, Risby TH. Breath biomarkers for detection of human liver diseases: preliminary study. Biomarkers 7: 174-187, 2002.
136. Sen N, Snyder SH. Protein modifications involved in neurotransmitter and gasotransmitter signaling. Trends Neurosci 2010.
137. Sen U, Mishra PK, Tyagi N, Tyagi SC. Homocysteine to hydrogen sulfide or hypertension. Cell Biochem Biophys 57: 49-58, 2010.
138. Sen U, Munjal C, Qipshidze N, Abe O, Gargoum R, Tyagi SC. Hydrogen sulfide regulates homocysteine-mediated glomerulosclerosis. Am J Nephrol 31: 442-455, 2010.
139. Shan Y, Zhao R, Geng W, Lin N, Wang X, Du X, Wang S. Protective effect of sulforaphane on human vascular endothelial cells against lipopolysaccharide-induced inflammatory damage. Cardiovasc Toxicol 10:139-145, 2010.
140. Shi L, Du J, Qi J, Wei B, Tang C, Tang X. Effects of high pulmonary blood flow on pulmonary vasculature structure and the gene expression of cystathionine-gamma-lyase. Beijing Da Xue Xue Bao 35: 566-570, 2003.
141. Shibuya N, Tanaka M, Yoshida M, Ogasawara Y, Togawa T, Ishii K, Kimura H. 3-Mercaptopyruvate sulfurtransferase produces hydrogen sulfide and bound sulfane sulfur in the brain. Antioxid Redox Signal 11: 703-714, 2009.
142. Shukla N, Rossoni G, Hotston M, Sparatore A, Del SP, Tazzari V, Persad R, Angelini GD, Jeremy JY. Effect of hydrogen sulphidedonating sildenafil (ACS6) on erectile function and oxidative stress in rabbit isolated corpus cavernosum and in hypertensive rats. BJU Int 103: 1522-1529, 2009.
143. Singh S, Padovani D, Leslie RA, Chiku T, Banerjee R. Relative contributions of cystathionine beta-synthase and gamma-cystathionase to H2S biogenesis via alternative trans-sulfuration reactions. J Biol Chem 284: 22457-22466, 2009.
144. Smith HS. Hydrogen sulfide's involvement in modulating nociception. Pain Physician 12: 901-910, 2009.
145. 2S-releasing aspirin. Free Radic Biol Med 46: 586-592, 2009.
146. Srilatha B, Adaikan PG, Moore PK. Possible role for the novel gasotransmitter hydrogen sulphide in erectile dysfunction-a pilot study. Eur J Pharmacol 535: 280-282, 2006.
147. Srilatha B, Hu L, Adaikan GP, Moore PK. Initial characterization of hydrogen sulfide effects in female sexual function. J Sex Med 6: 1875-1884, 2009.
148. Stipanuk MH. Sulfur amino acid metabolism: pathways for production and removal of homocysteine and cysteine. Annu Rev Nutr 24: 539-577, 2004.
149. Stipanuk MH, Ueki I. Dealing with methionine/homocysteine sulfur: cysteine metabolism to taurine and inorganic sulfur. J Inherit Metab Dis 34: 17-32, 2011.
150. Studer SM, Orens JB, Rosas I, Krishnan JA, Cope KA, Yang S, Conte JV, Becker PB, Risby TH. Patterns and significance of exhaledbreath biomarkers in lung transplant recipients with acute allograft rejection. J Heart Lung Transplant 20: 1158-1166, 2001.
151. Sugiura Y, Kashiba M, Maruyama K, Hoshikawa K, Sasaki R, Saito K, Kimura H, Goda N, Suematsu M. Cadmium exposure alters metabolomics of sulfur-containing amino acids in rat testes. Antioxid Redox Signal 7: 781-787, 2005.
152. Svoronos PDN, Bruno TJ. Carbonyl sulfide: a review of its chemistry and properties. Ind Eng Chem Res 41: 5321-5336, 2002.
153. Szabó C. Hydrogen sulphide and its therapeutic potential. Nat Rev Drug Discov 6: 917-935, 2007.
154. Szabo C. Gaseotransmitters: new frontiers for translational science. Sci Transl Med 2: 59ps54, 2010.
155. Szabo C, Papapetropoulos A. Hydrogen sulfide and angiogenesis: mechanisms and applications. Br J Pharmacol. In press.
156. Szabo G, Veres G, Radovits T, Gero D, Modis K, Miesel-Groschel C, Horkay F, Karck M, Szabo C. Cardioprotective effects of hydrogen sulfide. Nitric Oxide. In press.
157. Tamizhselvi R, Koh YH, Sun J, Zhang H, Bhatia M. Hydrogen sulfide induces ICAM-1 expression and neutrophil adhesion to caerulein-treated pancreatic acinar cells through NF-kappaB and Src-family kinases pathway. Exp Cell Res 316: 1625-1636, 2010.
158. Tamizhselvi R, Moore PK, Bhatia M. Hydrogen sulfide acts as a mediator of inflammation in acute pancreatitis: in vitro studies using isolated mouse pancreatic acinar cells. J Cell Mol Med 11: 315-326, 2007.
159. Tamizhselvi R, Moore PK, Bhatia M. Inhibition of hydrogen sulfide synthesis attenuates chemokine production and protects mice against acute pancreatitis and associated lung injury. Pancreas 36: e24-e31, 2008.
160. Tan BH, Wong PT, Bian JS. Hydrogen sulfide: a novel signaling molecule in the central nervous system. Neurochem Int 56: 3-10, 2010.
161. Tang G, Wu L, Wang R. The effect of hydroxylamine on KATP channels in vascular smooth muscle and underlying mechanisms. Mol Pharmacol 67: 1723-1731, 2005.
162. Tang XQ, Shen XT, Huang YE, Ren YK, Chen RQ, Hu B, He JQ, Yin WL, Xu JH, Jiang ZS. Hydrogen sulfide antagonizes homocysteine-induced neurotoxicity in PC12 cells. Neurosci Res 68: 241-249, 2010.
163. Tangerman A. Measurement and biological significance of the volatile sulfur compounds hydrogen sulfide, methanethiol, and dimethyl sulfide in various biological matrices. J Chromatogr B Analyt Technol Biomed Life Sci 2009.
164. Taniguchi S, Kang L, Kimura T, Niki I. Hydrogen sulphide protects mouse pancreatic beta-cells from cell death induced by oxidative stress, but not by endoplasmic reticulum stress. Br J Pharmacol 162: 1171-1178, 2010.
165. Tay AS, Hu LF, Lu M, Wong PT, Bian JS. Hydrogen sulfide protects neurons against hypoxic injury via stimulation of ATP-sensitive potassium channel/protein kinase C/extracellular signal-regulated kinase/heat shock protein 90 pathway. Neuroscience 167: 277-286, 2010.
166. Telezhkin V, Brazier SP, Cayzac S, Muller CT, Riccardi D, Kemp PJ. Hydrogen sulfide inhibits human BK(Ca) channels. Adv Exp Med Biol 648: 65-72, 2009.
167. Telezhkin V, Brazier SP, Cayzac SH, Wilkinson WJ, Riccardi D, Kemp PJ. Mechanism of inhibition by hydrogen sulfide of native and recombinant BKCa channels. Respir Physiol Neurobiol 172: 169-178, 2010.
168. Tiranti V, Viscomi C, Hildebrandt T, Di M, I, Mineri R, Tiveron C, Levitt MD, Prelle A, Fagiolari G, Rimoldi M, Zeviani M. Loss of ETHE1, a mitochondrial dioxygenase, causes fatal sulfide toxicity in ethylmalonic encephalopathy. Nat Med 15: 200-205, 2009.
169. Toombs CF, Insko MA, Wintner EA, Deckwerth TL, Usansky H, Jamil K, Goldstein B, Cooreman M, Szabo C. Detection of exhaled hydrogen sulphide gas in healthy human volunteers during intravenous administration of sodium sulphide. Br J Clin Pharmacol 69: 626-636, 2010.
170. Trevisani M, Patacchini R, Nicoletti P, Gatti R, Gazzieri D, Lissi N, Zagli G, Creminon C, Geppetti P, Harrison S. Hydrogen sulfide causes vanilloid receptor 1-mediated neurogenic inflammation in the airways. Br J Pharmacol 145: 1123-1131, 2005.
171. Tripatara P, Patel NS, Brancaleone V, Renshaw D, Rocha J, Sepodes B, Mota-Filipe H, Perretti M, Thiemermann C. Characterisation of cystathionine gamma-lyase/hydrogen sulphide pathway in ischaemia/reperfusion injury of the mouse kidney: an in vivo study. Eur J Pharmacol 606: 205-209, 2009.
172. Wagner CA. Hydrogen sulfide: a new gaseous signal molecule and blood pressure regulator. J Nephrol 22: 173-176, 2009.
173. Wagner F, Asfar P, Calzia E, Radermacher P, Szabo C. Bench-tobedside review: Hydrogen sulfide-the third gaseous transmitter: applications for critical care. Crit Care 13: 213, 2009.
174. Wallace JL. Hydrogen sulfide-releasing anti-inflammatory drugs. Trends Pharmacol Sci 28: 501-505, 2007.
175. Wallace JL. Physiological and pathophysiological roles of hydrogen sulfide in the gastrointestinal tract. Antioxid Redox Signal 12: 1125-1133, 2010.
176. Wallace JL, Dicay M, McKnight W, Martin GR. Hydrogen sulfide enhances ulcer healing in rats. FASEB J 21: 4070-4076, 2007.
177. Wallace JL, Vong L, McKnight W, Dicay M, Martin GR. Endogenous and exogenous hydrogen sulfide promotes resolution of colitis in rats. Gastroenterology 137: 569-578, 2009.
178. Wang Q, Wang XL, Liu HR, Rose P, Zhu YZ. Protective effects of cysteine analogues on acute myocardial ischemia: novel modulators of endogenous H(2)S production. Antioxid Redox Signal 12: 1155-1165, 2010.
179. Wang R. Two's company, three's a crowd: can H2S be the third endogenous gaseous transmitter? FASEB J 16: 1792-1798, 2002.
180. Wang R. Hydrogen sulfide: a new EDRF. Kidney Int 76: 700-704, 2009.
181. Webb GD, Lim LH, Oh VM, Yeo SB, Cheong YP, Ali MY, El OR, Lee CN, Wong PS, Caleb MG, Salto-Tellez M, Bhatia M, Chan ES, Taylor EA, Moore PK. Contractile and vasorelaxant effects of hydrogen sulfide and its biosynthesis in the human internal mammary artery. J Pharmacol Exp Ther 324: 876-882, 2008.
182. Wei HL, Zhang CY, Jin HF, Tang CS, Du JB. Hydrogen sulfide regulates lung tissue-oxidized glutathione and total antioxidant capacity in hypoxic pulmonary hypertensive rats. Acta Pharmacol Sin 29: 670-679, 2008.
183. Whiteman M, Cheung NS, Zhu YZ, Chu SH, Siau JL, Wong BS, Armstrong JS, Moore PK. Hydrogen sulphide: a novel inhibitor of hypochlorous acid-mediated oxidative damage in the brain? Biochem Biophys Res Commun 326: 794-798, 2005.
184. Whiteman M, Li L, Kostetski I, Chu SH, Siau JL, Bhatia M, Moore PK. Evidence for the formation of a novel nitrosothiol from the gaseous mediators nitric oxide and hydrogen sulphide. Biochem Biophys Res Commun 343: 303-310, 2006.
185. Whiteman M, Moore PK. Hydrogen sulfide and the vasculature: a novel vasculoprotective entity and regulator of nitric oxide bioavailability? J Cell Mol Med 13: 488-507, 2009.
186. Whitfield NL, Kreimier EL, Verdial FC, Skovgaard N, Olson KR. A Reappraisal of H2S/sulfide concentration in vertebrate blood and its potential significance in ischemic preconditioning and vascular signaling. Am J Physiol Regul Integr Comp Physiol 294: R1930-R1937, 2008.
187. Williams KT, Schalinske KL. Homocysteine metabolism and its relation to health and disease. Biofactors 36: 19-24, 2010.
188. Wintner EA, Deckwerth TL, Langston W, Bengtsson A, Leviten D, Hill P, Insko MA, Dumpit R, VandenEkart E, Toombs CF, Szabo C. A monobromobimane-based assay to measure the pharmacokinetic profile of reactive sulphide species in blood. Br J Pharmacol 160: 941-957, 2010.
189. Wojcicka G, Jamroz-Wisniewska A, Atanasova P, Chaldakov GN, Chylinska-Kula B, Beltowski J. Differential effects of statins on endogenous H2S formation in perivascular adipose tissue. Pharmacol Res 63: 68-76, 2011.
190. Woodall GM, Smith RL, Granville GC. Proceedings of the Hydrogen Sulfide Health Research and Risk Assessment Symposium October 31-November 2, 2000. Inhal Toxicol 17: 593-639, 2005.
191. Xia M, Chen L, Muh RW, Li PL, Li N. Production and actions of hydrogen sulfide, a novel gaseous bioactive infstance, in the kidneys. J Pharmacol Exp Ther 329: 1056-1062, 2009.
192. Xu Z, Prathapasinghe G, Wu N, Hwang SY, Siow YL, OK. Ischemiareperfusion reduces cystathionine-β-synthase-mediated hydrogen sulfide generation in the kidney. Am J Physiol Renal Physiol 297: F27-F35, 2009.
193. Ye L, Dinkova-Kostova AT, Wade KL, Zhang Y, Shapiro TA, Talalay P. Quantitative determination of dithiocarbamates in human plasma, serum, erythrocytes and urine: pharmacokinetics of broccoli sprout isothiocyanates in humans. Clin Chim Acta 316: 43-53, 2002.
194. Yong QC, Cheong JL, Hua F, Deng LW, Khoo YM, Lee HS, Perry A, Wood M, Whiteman M, Bian JS. Regulation of heart function by endogenous gaseous mediators. Cross-talk between nitric oxide and hydrogen sulfide. Antioxid Redox Signal. In press.
195. Yong QC, Hu LF, Wang S, Huang D, Bian JS. Hydrogen sulfide interacts with nitric oxide in the heart: possible involvement of nitroxyl. Cardiovasc Res 88: 482-491, 2010.
196. Yu YP, Li ZG, Wang DZ, Zhan X, Shao JH. Hydrogen sulfide as an effective and specific novel therapy for acute carbon monoxide poisoning. Biochem Biophys Res Commun 404: 6-9, 2011.
197. Yuan P, Xue H, Zhou L, Qu L, Li C, Wang Z, Ni J, Yu C, Yao T, Huang Y, Wang R, Lu L. Rescue of mesangial cells from high glucose-induced over-proliferation and extracellular matrix secretion by hydrogen sulfide. Nephrol Dial Transplant. In press.
198. Yusof M, Kamada K, Kalogeris T, Gaskin FS, Korthuis RJ. Hydrogen sulfide triggers late-phase preconditioning in postischemic small intestine by an NO- and p38 MAPK-dependent mechanism. Am J Physiol Heart Circ Physiol 296: H868-H876, 2009.
199. Zhang C, Du J, Bu D, Yan H, Tang X, Tang C. The regulatory effect of hydrogen sulfide on hypoxic pulmonary hypertension in rats. Biochem Biophys Res Commun 302: 810-816, 2003.
200. Zhang H, Bhatia M. Hydrogen sulfide: a novel mediator of leukocyte activation. Immunopharmacol Immunotoxicol 30: 631-645, 2008.
201. Zhang H, Gao Y, Zhao F, Dai Z, Meng T, Tu S, Yan Y. Hydrogen sulfide reduces mRNA and protein levels of beta-site amyloid precursor protein cleaving enzyme 1 in PC12 cells. Neurochem Int 58: 169-175, 2011.
202. Zhang Q, Du J, Zhou W, Yan H, Tang C, Zhang C. Impact of hydrogen sulfide on carbon monoxide/heme oxygenase pathway in the pathogenesis of hypoxic pulmonary hypertension. Biochem Biophys Res Commun 317: 30-37, 2004.
203. 2S-induced vasorelaxation and underlying cellular and molecular mechanisms. Am J Physiol Heart Circ Physiol 283: H474-H480, 2002.
204. 2S as a novel endogenous KATP channel opener. EMBO J 20: 6008-6016, 2001.
205. 2S) donors. J Am Chem Soc 133: 15-17, 2011.
206. Zhong G, Chen F, Chengy Tang C, Du J. The role of hydrogen sulfide generation in the pathogenesis of hypertension in rats induced by inhibition of nitric oxide synthase. J Hypertens 21: 1897-1885, 2003.
207. Zhong GZ. Hydrogen Sulfide-a potent multichannel anti-arrhythmic drug. J Cardiovasc Dis Res 1: 37-39, 2010.
208. Zhu H, Jia Z, Strobl JS, Ehrich M, Misra HP, Li Y. Potent induction of total cellular and mitochondrial antioxidants and phase 2 enzymes by cruciferous sulforaphane in rat aortic smooth muscle cells: cytoprotection against oxidative and electrophilic stress. Cardiovasc Toxicol 8: 115-125, 2008.